Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma

Por Engels, C C, Fontein, D B Y, Kuppen, P J K, de Kruijf, E M, Smit, V T H B M, Nortier, J W R, Liefers, G J, van de Velde, C J H, Bastiaannet, E
Publicado em 2014

Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study

Por van Nes, J. G. H., Fontein, D. B. Y., Hille, E. T. M., Voskuil, D. W., van Leeuwen, F. E., de Haes, J. C. J. M., Putter, H., Seynaeve, C., Nortier, J. W. R., van de Velde, C. J. H.
Publicado em 2012